ApoE: The role of conserved residues in defining function

Protein Science

Volumn 24, Issue 1, 2015, Pages 138-144

  Frieden, Carl ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

allosteric pathway; amino acid sequences; A binding; heparin binding; LDL receptor binding; lipoprotein binding

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; ARGININE; CYSTEINE; HEPARIN BINDING PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; THREONINE; ANTICOAGULANT AGENT; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HEPARIN; PROTEIN BINDING;

ALLOSTERISM; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DEUTERIUM HYDROGEN EXCHANGE; ENZYME ACTIVITY; HUMAN; LIGAND BINDING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DATABASE; PROTEIN FUNCTION; PROTEIN STRUCTURE; SURFACE PLASMON RESONANCE; ALZHEIMER DISEASE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CONSERVED SEQUENCE; METABOLISM; MOLECULAR GENETICS;

MAMMALIA;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PEPTIDES; ANTICOAGULANTS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BINDING SITES; CONSERVED SEQUENCE; HEPARIN; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; RECEPTORS, LDL;

EID: 84928954952     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2597     Document Type: Article

References (39)

1. McIntosh AM, Bennett C, Dickson D, Anestis SF, Watts DP, Webster TH, Fontenot MB, Bradley BJ, (2012) The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes). PLoS One 7: e47760.
2. Finch CE, (2010) Evolution in health and medicine Sackler colloquium: evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci USA 107 (Suppl 1): 1718-1724.
3. Finch CE, Sapolsky RM, (1999) The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 20: 407-428.
4. Weisgraber KH, Rall SC, Jr, Mahley RW, (1981) Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077-9083.
5. Rall SC, Jr, Weisgraber KH, Mahley RW, (1982) Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257: 4171-4178.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA, (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
7. Rebeck GW, Kindy M, LaDu MJ, (2002) Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J Alzheimers Dis 4: 145-154.
8. Chen J, Li Q, Wang J, (2011) Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci USA 108: 14813-14818.
9. Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA, (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252: 1817-1822.
10. Hatters DM, Peters-Libeu CA, Weisgraber KH, (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31: 445-454.
11. Frieden C, Garai K, (2013) Concerning the structure of apoE. Prot Sci 22: 1820-1825.
12. Huang RYC, Garai K, Frieden C, Gross ML, (2011) Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization. Biochemistry 50: 9273-9282.
13. Frieden C, Garai K, (2012) Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease. Proc Natl Acad Sci USA 109: 8913-8918.
14. Gau B, Garai K, Frieden, Gross ML, (2011) Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4. Biochemistry 50: 8117-8126.
15. Dong LM, Weisgraber KH, (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271: 19053-19057.
16. Lalazar A, Weisgraber KH, Rall SC, Jr, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley RW, Vogel T, (1988) Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem 263: 3542-3545.
17. Croy JE, Brandon T, Komives EA, (2004) Two apolipoprotein E mimetic peptides, ApoE(130-149) and ApoE(141-155)2, bind to LRP1. Biochemistry 43: 7328-7335.
18. Innerarity TL, Friedlander EJ, Rall SC, Jr, Weisgraber KH, Mahley RW, (1983) The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. J Biol Chem 258: 12341-12347.
19. Weisgraber KH, Innerarity TL, Harder KJ, Mahley RW, Milne RW, Marcel YL, Sparrow JT, (1983) The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem 258: 12348-12354.
20. Dong LM, Parkin S, Trakhanov SD, Rupp B, Simmons T, Arnold KS, Newhouse YM, Innerarity TL, Weisgraber KH, (1996) Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia. Nat Struct Biol 3: 718-722.
21. Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S, (2009) Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry 48: 3025-3032.
22. Dong LM, Wilson C, Wardell MR, Simmons T, Mahley RW, Weisgraber KH, Agard DA, (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem 269: 22358-22365.
23. Westerlund JA, Weisgraber KH, (1993) Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization. J Biol Chem 268: 15745-15750.
24. Cardin AD, Hirose N, Blankenship DT, Jackson RL, Harmony JA, Sparrow DA, Sparrow JT, (1986) Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem Biophys Res Commun 134: 783-789.
25. Weisgraber KH, Rall SC, Jr, Mahley RW, Milne RW, Marcel YL, Sparrow JT, (1986) Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem 261: 2068-2076.
26. Dong J, Peters-Libeu CA, Weisgraber KH, Segelke BW, Rupp B, Capila I, Hernaiz MJ, LeBrun LA, Linhardt RJ, (2001) Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Biochemistry 40: 2826-2834.
27. Saito H, Dhanasekaran P, Nguyen D, Baldwin F, Weisgraber KH, Wehrli S, Phillips MC, Lund-Katz S, (2003) Characterization of the heparin binding sites in human apolipoprotein E. J Biol Chem 278: 14782-14787.
28. Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H, (2005) Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J Biol Chem 280: 5414-5422.
29. Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM, (2013) ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci USA 110: E1807-1816.
30. Holtzman DM, (2001) Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci 17: 147-155.
31. Basak JM, Kim J, Pyatkivskyy Y, Wildsmith KR, Jiang H, Parsadanian M, Patterson BW, Bateman RJ, Holtzman DM, (2012) Measurement of apolipoprotein E and amyloid beta clearance rates in the mouse brain using bolus stable isotope labeling. Mol Neurodegener 7: 14-27.
32. Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE, (2013) Evidence for impaired amyloid beta clearance in Alzheimer's disease. Alzheimers Res Ther 5: 33-39.
33. Manelli AM, Stine WB, Van Eldik LJ, LaDu MJ, (2004) ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. J Mol Neurosci 23: 235-246.
34. Li J, Kanekiyo T, Shinohara M, Zhang Y, LaDu MJ, Xu H, Bu G, (2012) Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J Biol Chem 287: 44593-44601.
35. Ly S, Altman R, Petrlova J, Lin Y, Hilt S, Huser T, Laurence TA, Voss JC, (2013) Binding of apolipoprotein e inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy. J Biol Chem 288: 11628-11635.
36. Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C, (2014) The binding of apolipoprotein E to oligomers and fibrils of amyloid-beta alters the kinetics of amyloid aggregation. Biochemistry 53: 6323-6331.
37. Perugini MA, Schuck P, Howlett GJ, (2000) Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid. J Biol Chem 275: 36758-36765.
38. Garai K, Frieden C, (2010) The association-dissociation behavior of the ApoE proteins: kinetic and equilibrium studies. Biochemistry 49: 9533-9541.
39. Peters-Libeu CA, Newhouse Y, Hatters DM, Weisgraber KH, (2006) Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine. J Biol Chem 281: 1073-1079.